Thromb Haemost 2005; 93(01): 172-174
DOI: 10.1055/s-0037-1617410
Case Report
Schattauer GmbH

Fibroblast growth factor 2 and the transcription factor Egr-1 localise to endothelial cell microvascular channels in human coronary artery occlusion

Ravinay Bhindi
1   Centre for Vascular Research, Sydney, Australia
2   Cardiology Department, Concord Repatriation General Hospital, Sydney, Australia
,
David Brieger
2   Cardiology Department, Concord Repatriation General Hospital, Sydney, Australia
,
Hideto Ishii
1   Centre for Vascular Research, Sydney, Australia
,
Nick Di Girolamo
3   Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, Australia
,
Rakesh K. Kumar
3   Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, Australia
,
Levon M. Khachigian
1   Centre for Vascular Research, Sydney, Australia
,
Harry C. Lowe
1   Centre for Vascular Research, Sydney, Australia
2   Cardiology Department, Concord Repatriation General Hospital, Sydney, Australia
› Author Affiliations
Further Information

Correspondence to:

Harry C. Lowe
Centre for Vascular Research
School of Medical Sciences
University of New South Wales
Sydney NSW 2052, Australia
Phone: 61 2 9767 6296   
Fax: 61 2 9767 6994   

Publication History

Received 14 June 2004

Accepted after resubmission 25 October 2004

Publication Date:
15 December 2017 (online)

 

 


#
  • References

  • 1 Bailey SR. Opportunity lost: the continuing challenge of chronic total occlusions. Catheter Cardiovasc Interv 2003; 59: 312-3.
  • 2 Srivatsa SS, Edwards WD, Boos CM. et al Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition. J Am Coll Cardiol 1997; 29: 955-63.
  • 3 Szebenyi G, Fallon JF. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 1999; 185: 45-106.
  • 4 Detillieux KA, Sheikh F, Kardami E. et al Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 2003; 57: 8-19.
  • 5 Khachigian LM, Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 1997; 81: 457-61.
  • 6 Santiago FS, Lowe HC, Day FL. et al Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor- 2. Am J Pathol 1999; 154: 937-44.
  • 7 Fahmy RG, Dass CR, Sun LQ. et al Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 2003; 9: 1026-32.
  • 8 Neufeld G, Cohen T, Gengrinovitch S. et al Vascular endothelial growth factor (VEGF) and its receptors. FASEB 1999; 13: 9-22.
  • 9 Waltham M, Burnand KG, Collins M. et al Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation. Thromb Haemost 2003; 89: 169-76.
  • 10 Deindl E, Buschmann I, Hoefer IE. et al Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 2001; 89: 779-86.
  • 11 Yan SF, Mackman N, Kisiel W. et al Hypoxia / Hypoxemia Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arterioscler Thromb Vasc Biol 1999; 19: 2029-35.
  • 12 Aviles RJ, Annex BH, Lederman RJ. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br J Pharmacol 2003; 140: 637-46.

Correspondence to:

Harry C. Lowe
Centre for Vascular Research
School of Medical Sciences
University of New South Wales
Sydney NSW 2052, Australia
Phone: 61 2 9767 6296   
Fax: 61 2 9767 6994   

  • References

  • 1 Bailey SR. Opportunity lost: the continuing challenge of chronic total occlusions. Catheter Cardiovasc Interv 2003; 59: 312-3.
  • 2 Srivatsa SS, Edwards WD, Boos CM. et al Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition. J Am Coll Cardiol 1997; 29: 955-63.
  • 3 Szebenyi G, Fallon JF. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 1999; 185: 45-106.
  • 4 Detillieux KA, Sheikh F, Kardami E. et al Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 2003; 57: 8-19.
  • 5 Khachigian LM, Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 1997; 81: 457-61.
  • 6 Santiago FS, Lowe HC, Day FL. et al Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor- 2. Am J Pathol 1999; 154: 937-44.
  • 7 Fahmy RG, Dass CR, Sun LQ. et al Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 2003; 9: 1026-32.
  • 8 Neufeld G, Cohen T, Gengrinovitch S. et al Vascular endothelial growth factor (VEGF) and its receptors. FASEB 1999; 13: 9-22.
  • 9 Waltham M, Burnand KG, Collins M. et al Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation. Thromb Haemost 2003; 89: 169-76.
  • 10 Deindl E, Buschmann I, Hoefer IE. et al Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 2001; 89: 779-86.
  • 11 Yan SF, Mackman N, Kisiel W. et al Hypoxia / Hypoxemia Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arterioscler Thromb Vasc Biol 1999; 19: 2029-35.
  • 12 Aviles RJ, Annex BH, Lederman RJ. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br J Pharmacol 2003; 140: 637-46.